Research Article
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway
Figure 6
A graphical summary for the cardioprotective effect of bardoxolone methyl (BARD) against myocardial I/R injury.